LSTM Home > LSTM Research > LSTM Online Archive

Development of a generic high-throughput screening assay for profiling snake venom protease activity after high-resolution chromatographic fractionation

Neumann, C, Slagboom, J, Somsen, GW, Vonk, F, Casewell, Nicholas ORCID: https://orcid.org/0000-0002-8035-4719, Cardoso, CL and Kool, J (2020) 'Development of a generic high-throughput screening assay for profiling snake venom protease activity after high-resolution chromatographic fractionation'. Toxicon, Vol 178, pp. 61-68.

[img] Text
Neumann et al 2020_Protease-Toxicon-Feb-20.docx - Accepted Version

Download (105kB)
[img] Text
Neuman et al 2020_Protease-Figures-Toxicon_Feb-20.docx - Supplemental Material

Download (5MB)

Abstract

Snakebite causes upwards of 1.8 million envenomings, 138,000 deaths and 500,000 cases of long term morbidity each year. Viper snake venoms (family Viperidae) generally contain a high proportion of proteases, which can cause devastating effects, such as hemorrhage, coagulopathy, edema, necrosis, and severe pain, in envenomed victims. In this study, analytical techniques were combined with enzymatic assays to develop a novel method for the detection of snake venom protease activity by using rhodamine-110-peptide substrate. In the so called at-line nanofractionation set up, crude venoms were first separated with reversed phase liquid chromatography, after which fractions were collected onto 384-well plates. Protease activity assays were then performed in the 384-well plates and bioassay chromatograms were constructed revealing protease activity. Parallel obtained UV absorbance, MS and proteomics data from a previous study facilitated toxin identification. The application of the rhodamine-110-peptide substrate assay showed significantly greater sensitivity compared to prior assays using casein-FITC as the substrate. Moreover, cross referencing UV and MS data and resulted in the detection of a number of tentative proteases suspected to exhibit protease activity, including snake venom serine proteases from Calloselasma rhodostoma and Daboia russelli venom and a snake venom metalloproteinase from the venom of Echis ocellatus. Our data demonstrate that his methodology can be a useful tool for selectively identifying snake venom proteases, and can be applied to provide a better understanding of protease-induced pathologies and the development of novel therapeutics for treating snakebite.

Item Type: Article
Subjects: QU Biochemistry > Enzymes > QU 143 Enzyme inhibitors
QV Pharmacology > Drug Standardization. Pharmacognosy. Medicinal Plants > QV 771 Standardization and evaluation of drugs
WD Disorders of Systemic, Metabolic or Environmental Origin, etc > Animal Poisons > WD 410 Reptiles
Faculty: Department: Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI): https://doi.org/10.1016/j.toxicon.2020.02.015
Depositing User: Mary Creegan
Date Deposited: 02 Mar 2020 15:09
Last Modified: 26 Feb 2021 02:02
URI: https://archive.lstmed.ac.uk/id/eprint/13802

Statistics

View details

Actions (login required)

Edit Item Edit Item